Skip to main content
SpringerLink
Log in

Beyond cholesterol lowering: Deciphering the benefits of dietary intervention on cardiovascular diseases

  • Clinical Trials Review
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References and Recommended Reading

  1. America Heart Association Heart and Stroke Fact Book, 2000.

  2. Gould AL, Rossouw JE, Santanello NC, et al.: Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 1998, 97:946–952.

    PubMed  CAS  Google Scholar 

  3. Adult Treatment Panel II: Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. National Cholesterol Education Program, National Heart, Lung, and Blood Institute, United States Department of Health and Human Services, 1993.

  4. Yu-Poth S, Zhao G, Etherton T, et al.: Effects of the National Cholesterol Education Program’s Step I and Step II dietary intervention programs on the cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999, 69:632–646.

    PubMed  CAS  Google Scholar 

  5. Grundy SM, Balady GJ, Criqui MH, et al.: AHA scientific statement: primary prevention of coronary heart disease: guidance from Framingham. Circulation 1998,97:1876–1887.

    PubMed  CAS  Google Scholar 

  6. Kimura N, Keys A: Coronary heart disease in seven countries. Circulation 1970, 41:1–211.

    Google Scholar 

  7. Hornstra G, Barth CA, Galli C, et al.: Functional food science and the cardiovascular system. Br J Nutr 1998, 80(S1):S113-S146.

    Article  PubMed  CAS  Google Scholar 

  8. de Lorgeril M, Renaud S, Mamelle N, et al.: Mediterranean alpha-linolenic acid—risk diet in secondary prevention of coronary heart disease. Lancet 1994, 343:1454–1459.

    Article  PubMed  Google Scholar 

  9. de Longeril M: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarctionL: final report of the Lyon Diet Heart study. Circulation 1999, 99:779–785.

    Google Scholar 

  10. Gissi-Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447–455.

    Article  Google Scholar 

  11. Burr ML, Fehily AM, Gilbert JF, et al.: Effects of changes in fat, fish, and fibre intakes of death and myocardial reinfarction; diet and reinfarction trial (DART). Lancet 1989, 334:757–761.

    Article  Google Scholar 

  12. Kant AK, Schatzkin A, Graubard BI, et al.: A prospective study of diet quality and mortality in women. JAMA 2000, 283:2109–2115.

    Article  PubMed  CAS  Google Scholar 

  13. Leren P: The Oslo Diet-Heart study: eleven-year report. Circulation 1970, 42:935–942.

    PubMed  CAS  Google Scholar 

  14. Dayton S: A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation 1969, 40(S2):II1-II63.

    Google Scholar 

  15. Canner PL, Berge KG, Wenger NK, et al.: Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986, 8:1245.

    Article  PubMed  CAS  Google Scholar 

  16. Committee of Principal Investigators: WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Lancet 1984, 2:279–283.

    Google Scholar 

  17. Frick MH, Elo O, Haapa K, et al.: Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987, 317:1237–1242.

    Article  PubMed  CAS  Google Scholar 

  18. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984, 251:365–372.

    Article  Google Scholar 

  19. Manninen V, Elo MO, Frick MH, et al.: Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart study. JAMA 1988, 260:641–649.

    Article  PubMed  CAS  Google Scholar 

  20. Research Committee of the Scottish Society of Physicians: Ischaemic Heart Disease: a secondary prevention trial using clofibrate. BMJ 1971, 4:775.

    Article  Google Scholar 

  21. Long Term Intervention with Pravastatin Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial levles. N Engl J Med 1998, 339:1349–1357.

    Article  Google Scholar 

  22. CARE Trial Investigators: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996, 335:1001–1009.

    Article  Google Scholar 

  23. Scandinavian Simvastatin Survival Group: Randomised trial of cholesterol-lowering in 4444 patients with CHD: the Scandinavian Simvastatin Study (4S). Lancet 1994, 344:1384–1389.

    Article  Google Scholar 

  24. Shepherd J, Cobbe SM, Ford I, et al.: Prevention of CHD with pravastatin in men with hypercholesterolemia. N Engl J Med 1995, 333:1301–1317.

    Article  PubMed  CAS  Google Scholar 

  25. Downs JR, Clearfield M, Weis S, et al.: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998, 279:1615–1622.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Strategic-Discovery Research Development, Ross Products Division Abbott Laboratories, 625 Cleveland Avenue, RP3-2, #105670, 43215, Columbus, OH, USA

    Vikkie A. Mustad PhD

  2. Nutrition Department, The Pennsylvania State University, 16802, University Park, PA, USA

    Penny M. Kris-Etherton PhD, RD

Authors
  1. Vikkie A. Mustad PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Penny M. Kris-Etherton PhD, RD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mustad, V.A., Kris-Etherton, P.M. Beyond cholesterol lowering: Deciphering the benefits of dietary intervention on cardiovascular diseases. Curr Atheroscler Rep 2, 461–466 (2000). https://doi.org/10.1007/s11883-000-0044-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-000-0044-x

Keywords

Search

Navigation